71144-35-9

Basic information

• Product Name: 3-fluoro-4,5-dihydroxybenzaldehyde
• Synonyms: 3-Fluoro-4,5-dihydroxybenzaldehyde; 71144-35-9; VHR CQ DQ EF
• CAS NO: 71144-35-9
• Molecular Formula: C₇H₅FO₃
• Molecular Weight: 156.1112
• Mol File: 71144-35-9.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 278.2°C at 760 mmHg
• Flash Point: 122°C
• Density: 1.527g/cm³
• Vapor Pressure: 0.00256mmHg at 25°C
• Refractive Index: 1.638
• CAS DataBase Reference: 3-fluoro-4,5-dihydroxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-fluoro-4,5-dihydroxybenzaldehyde(71144-35-9)
• EPA Substance Registry System: 3-fluoro-4,5-dihydroxybenzaldehyde(71144-35-9)

Safety Data

• Hazardous Substances Data: 71144-35-9(Hazardous Substances Data)

Upstream product

• 71924-61-3 3-fluoro-4,5-dimethoxybenzaldehyde 
• 79418-78-3 3-fluoro-4-hydroxy-5-methoxybenzaldehyde 

Downstream Products

• 71924-61-3 3-fluoro-4,5-dimethoxybenzaldehyde 
• 79418-78-3 3-fluoro-4-hydroxy-5-methoxybenzaldehyde 
• 79418-74-9 3-fluoro-4-methoxy-5-hydroxybenzaldehyde 
• 1283119-80-1 3,4-diethoxy-5-fluorobenzaldehyde 
• 1283117-76-9 4-(3-ethoxy-5-fluoro-4-hydroxyphenyl)-5,6-diphenyl-3,4-dihydropyrimidin-2(1H)-one 
• 1283117-77-0 3-ethoxy-5-fluoro-4-hydroxybenzaldehyde 

Relevant articles and documents

SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES

The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Rational design, synthesis and biological evaluation of modular fluorogenic substrates with high affinity and selectivity for PTP1B

Protein-tyrosine phosphatase 1B (PTP1B) is a key regulatory enzyme in several signal transduction pathways, and its upregulation has been associated with type-2 diabetes, obesity and cancer. Selective determination of the functional significance of PTP1B

NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.